Stephane ROCHE, PhD, HDR

CEO & CTO

Researcher, Stéphane ROCHE holds a PhD in Biological and Medical Engineering and is a former University Hospital Assistant of the Grenoble Hospitals. Stéphane ROCHE also holds a Habilitation to Supervise Research. He has worked in the hospitals of Grenoble, Montpellier and Marseille. He has an important background in medical genetics, medical biochemistry and innovative therapies (ORCID).

Stephane Roche becomes CEO of Ventio

Stephane Roche becomes CEO of Ventio Technical Director for the past 2 years, Dr Stephane Roche took…

QMR Lucca 2022

QSM4SENIOR: Quantitative susceptibility mapping in the aging of the healthy brain. Miguel Guevara1,2…

sAPP & Abeta in CSF

Correlations between soluble alpha/beta forms of amyloid precursor protein and Abeta38, 40 and 42 in…

APP Ab38 Ab40 in FTD

Decreased sAβPPβ, Aβ38, and Aβ40 Cerebrospinal Fluid Levels in Frontotemporal Dementia Gabelle, Audr…

Preanalytical guidelines

Preanalytical guidelines for clinical proteomics investigation of biological fluids S Lehmann, S. Ro…

Biomarkers in CSF

Les marqueurs biologiques protéiques du liquide céphalorachidien : caractéristiques et implications …

Autoantibody in CSF

Auto-antibody profiling on high-density protein microarrays for biomarker discovery in the cerebrosp…

Clinical proteomics in CSF

Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers Stéphane Roc…